Tiziana Life Sciences Ltd. (NASDAQ: TLSA)
$0.81
N/A ( 0% ) 21.7K
Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in the developing transformative therapies for neurodegenerative and lung diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.
Market Data
Open
$0.81
Previous close
$0.81
Volume
21.7K
Market cap
$82.23M
Day range
$0.81 - $0.84
52 week range
$0.41 - $1.05
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
6-k | Quarterly Reports | 3 | Apr 23, 2024 |
6-k | Quarterly Reports | 4 | Apr 22, 2024 |
6-k | Quarterly Reports | 3 | Apr 19, 2024 |
6-k | Quarterly Reports | 3 | Apr 18, 2024 |
6-k | Quarterly Reports | 3 | Apr 11, 2024 |
6-k | Quarterly Reports | 3 | Mar 05, 2024 |
6-k | Quarterly Reports | 3 | Jan 08, 2024 |
6-k | Quarterly Reports | 3 | Jan 05, 2024 |
6-k | Quarterly Reports | 3 | Jan 05, 2024 |
6-k | Quarterly Reports | 3 | Dec 29, 2023 |